Evidence for consistency of the glycation gap in diabetes
- PMID: 21715524
- PMCID: PMC3142043
- DOI: 10.2337/dc10-1767
Evidence for consistency of the glycation gap in diabetes
Abstract
Objective: Discordance between HbA(1c) and fructosamine estimations in the assessment of glycemia is often encountered. A number of mechanisms might explain such discordance, but whether it is consistent is uncertain. This study aims to coanalyze paired glycosylated hemoglobin (HbA(1c))-fructosamine estimations by using fructosamine to determine a predicted HbA(1c), to calculate a glycation gap (G-gap) and to determine whether the G-gap is consistent over time.
Research design and methods: We included 2,263 individuals with diabetes who had at least two paired HbA(1c)-fructosamine estimations that were separated by 10 ± 8 months. Of these, 1,217 individuals had a third pair. The G-gap was calculated as G-gap = HbA(1c) minus the standardized fructosamine-derived HbA(1c) equivalent (FHbA(1c)). The hypothesis that the G-gap would remain consistent in individuals over time was tested.
Results: The G-gaps were similar in the first, second, and third paired samples (0.0 ± 1.2, 0.0 ± 1.3, and 0.0 ± 1.3, respectively). Despite significant changes in the HbA(1c) and fructosamine, the G-gap did not differ in absolute or relative terms and showed no significant within-subject variability. The direction of the G-gap remained consistent.
Conclusions: The G-gap appears consistent over time; thus, by inference any key underlying mechanisms are likely to be consistent. G-gap calculation may be a method of exploring and evaluating any such underlying mechanisms.
Figures
Similar articles
-
Level of glycation gap in a healthy subject.Ann Agric Environ Med. 2012;19(4):842-5. Ann Agric Environ Med. 2012. PMID: 23311817
-
Nontraditional markers of glycemia: associations with microvascular conditions.Diabetes Care. 2011 Apr;34(4):960-7. doi: 10.2337/dc10-1945. Epub 2011 Feb 18. Diabetes Care. 2011. PMID: 21335368 Free PMC article.
-
Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?Diabetes Metab. 2001 Nov;27(5 Pt 1):598-603. Diabetes Metab. 2001. PMID: 11694860
-
Difficulties in interpreting HbA(1c) results.Pol Arch Med Wewn. 2010 Apr;120(4):148-54. Pol Arch Med Wewn. 2010. PMID: 20424541 Review.
-
Potential Clinical Error Arising From Use of HbA1c in Diabetes: Effects of the Glycation Gap.Endocr Rev. 2019 Aug 1;40(4):988-999. doi: 10.1210/er.2018-00284. Endocr Rev. 2019. PMID: 31074800 Review.
Cited by
-
Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited.PLoS One. 2013 Jun 12;8(6):e66696. doi: 10.1371/journal.pone.0066696. Print 2013. PLoS One. 2013. PMID: 23776693 Free PMC article.
-
Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes.J Clin Endocrinol Metab. 2012 Apr;97(4):1067-72. doi: 10.1210/jc.2011-1894. Epub 2012 Jan 11. J Clin Endocrinol Metab. 2012. PMID: 22238408 Free PMC article.
-
The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability.Cureus. 2020 Aug 12;12(8):e9685. doi: 10.7759/cureus.9685. Cureus. 2020. PMID: 32923278 Free PMC article. Review.
-
Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait.PLoS One. 2019 Feb 15;14(2):e0212552. doi: 10.1371/journal.pone.0212552. eCollection 2019. PLoS One. 2019. PMID: 30768636 Free PMC article.
-
Association of glycation gap with mortality and vascular complications in diabetes.Diabetes Care. 2013 Oct;36(10):3247-53. doi: 10.2337/dc12-1040. Epub 2013 Jul 8. Diabetes Care. 2013. PMID: 23835697 Free PMC article.
References
-
- Macdonald DR, Hanson AM, Holland MR, Singh BM. Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis. Ann Clin Biochem 2008;45:421–425 - PubMed
-
- Hempe JM, Gomez R, McCarter RJ, Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002;16:313–320 - PubMed
-
- Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208–215 - PubMed
-
- Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004;21:657–665 - PubMed
-
- Kilpatrick ES. Problems in the assessment of glycaemic control in diabetes mellitus. Diabet Med 1997;14:819–831 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous